Roche introduces Navify brand for digital health solutions
Basel: Roche has announced at the HLTH 2022 meeting in Las Vegas, NV, US, that its digital health portfolio will now be available under the navify brand. The navify digital solutions help providers and patients 'navigate' and 'clarify' a wide range of touchpoints by activating insights that provide evidence on how to optimise operational processes and clinical decision making in...
Basel: Roche has announced at the HLTH 2022 meeting in Las Vegas, NV, US, that its digital health portfolio will now be available under the navify brand. The navify digital solutions help providers and patients 'navigate' and 'clarify' a wide range of touchpoints by activating insights that provide evidence on how to optimise operational processes and clinical decision making in healthcare.
"Today we are using navify digital solutions, such as algorithms, and data science to deliver insights that are actionable in healthcare, building on three decades of software experience with diagnostics in laboratories," said Moritz Hartmann, Head of Roche Information Solutions. "We are creating open digital ecosystems with labs, hospitals and medtech companies to bring the latest innovations faster to society to better serve patients, and to support clinicians in providing care for patients. These activities support our strategy to deliver insights that drive personalised care."
Together, navify brings new ways to:
- Improve interoperability of digital infrastructure: Today limited abilities to seamlessly connect and share data costs healthcare systems an est. $30 billion in the US alone,
- Use advanced analytics to deliver operational excellence, improved workflows, and patient-centric ways of working: A worldwide shortage of up to 15 million healthcare workers is predicted by 2030:2 providers face increasing workloads with less resources - finding additional efficiencies is a priority,
- Generate advanced medical insights that augment clinical decision support: 2 in 3 physicians are unsure if they are over- or underusing diagnostics, compared to their peers.
Read also: Roche Diagnostics, Redcliffe Labs collaborate for early Alzheimer's prediction
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd